ImmunoGen banks $20M up front in Lilly antibody-drug conjugate deal
21 December 2011
Donna Young
Please Login to read the full article.
21 December 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- EMILIA supports Roche's T-DM1 filing but MARIANNE will be key to market performance
- ImmunoGen shelves IMGN388 in solid cancers: little value lost
- Private equity player Celtic bankrolls new Swiss antibody-drug conjugate company
- Endo begins Mersana's foray into antibody-drug conjugates with $270 million deal
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
